0001103021-22-000029.txt : 20220208 0001103021-22-000029.hdr.sgml : 20220208 20220208205505 ACCESSION NUMBER: 0001103021-22-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220204 FILED AS OF DATE: 20220208 DATE AS OF CHANGE: 20220208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vollins James CENTRAL INDEX KEY: 0001757833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 22603530 MAIL ADDRESS: STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL STREET 2: 4131 PARK LAKE AVE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_164437168992570.xml FORM 4 X0306 4 2022-02-04 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001757833 Vollins James C/O BIODELIVERY SCIENCES INTL, INC. 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 See Remarks Common Stock 2022-02-04 4 S 0 18541 3.60 D 9872 D Common Stock 2022-02-04 4 F 0 9872 3.66 D 0 D The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan. The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to vesting Restricted Stock Units. General Counsel, Chief Compliance Officer & Corporate Secretary /s/ James Vollins 2022-02-08